These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The bridging conundrum: perioperative management of direct oral anticoagulants for venous thromboembolism. Berry J; Patell R; Zwicker JI J Thromb Haemost; 2023 Apr; 21(4):780-786. PubMed ID: 36709100 [TBL] [Abstract][Full Text] [Related]
3. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis. Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Sharma M; Cornelius VR; Patel JP; Davies JG; Molokhia M Circulation; 2015 Jul; 132(3):194-204. PubMed ID: 25995317 [TBL] [Abstract][Full Text] [Related]
5. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830 [TBL] [Abstract][Full Text] [Related]
6. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants. Testa S; Legnani C; Antonucci E; Paoletti O; Dellanoce C; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G; J Thromb Haemost; 2019 Jul; 17(7):1064-1072. PubMed ID: 31013383 [TBL] [Abstract][Full Text] [Related]
7. Use of Direct Oral Anticoagulants in Special Populations. Li A; Lopes RD; Garcia DA Hematol Oncol Clin North Am; 2016 Oct; 30(5):1053-71. PubMed ID: 27637307 [TBL] [Abstract][Full Text] [Related]
8. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
10. Managing the perioperative patient on direct oral anticoagulants. Leitch J; van Vlymen J Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198 [TBL] [Abstract][Full Text] [Related]
11. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation. Sarma A; Giugliano RP Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852 [TBL] [Abstract][Full Text] [Related]
12. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era. Toth PP Vasc Health Risk Manag; 2016; 12():23-34. PubMed ID: 26929637 [TBL] [Abstract][Full Text] [Related]
13. Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis. Nisly SA; Mihm AE; Gillette C; Davis KA; Tillett J J Thromb Thrombolysis; 2021 Oct; 52(3):817-827. PubMed ID: 33728575 [TBL] [Abstract][Full Text] [Related]
14. [Direct oral anticoagulant associated bleeding]. Godier A; Martin AC; Rosencher N; Susen S J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642 [TBL] [Abstract][Full Text] [Related]
15. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review. van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194 [TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in patients with cancer. Bossaer JB; Covert KL Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880 [TBL] [Abstract][Full Text] [Related]
17. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry. Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155 [TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB; Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309 [TBL] [Abstract][Full Text] [Related]
19. Direct Oral Anticoagulants: Laboratory Challenges and Antidotes. Beyer-Westendorf J; Köhler C Hamostaseologie; 2023 Feb; 43(1):37-43. PubMed ID: 36807818 [TBL] [Abstract][Full Text] [Related]
20. Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants. Chan NC; Bhagirath V; Dale BJ; Eikelboom JW Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1213-23. PubMed ID: 26471327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]